Skip to main content
Clinical Trials/JPRN-UMIN000020690
JPRN-UMIN000020690
Completed
未知

Biomarker evaluation as the cardiotoxic evaluation index in the molecular target drug for breast cancer treatment - Biomarker evaluation as the cardiotoxic evaluation index in the molecular target drug for breast cancer treatment

Division of Breast Oncology,Cancer Institute Hospital of Japanese Foundation for Cancer Research0 sites113 target enrollmentJanuary 21, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
HER2-positive breast cancer
Sponsor
Division of Breast Oncology,Cancer Institute Hospital of Japanese Foundation for Cancer Research
Enrollment
113
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 21, 2016
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Division of Breast Oncology,Cancer Institute Hospital of Japanese Foundation for Cancer Research

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)The patient who withdrew an agreement 2\)Examination participation of the patients is taken as inappropriate by the medical attendant

Outcomes

Primary Outcomes

Not specified

Similar Trials